# Enhatch

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enhatch

- Industry: Software
- Headquarters: Hasbrouck Heights, US
- Website: www.enhatch.com
- Total disclosed funding: $9M
- Latest round: Series A (Jun 21, 2021)
- Investors on record: 5

## About

Enhatch, based in the US, develops an ecosystem of AI-driven orthopedic preoperative planning solutions, enhancing collaboration among surgical teams with personalized 3D printed implants and surgical guides for improved patient outcomes.Enhatch is focused on revolutionizing orthopedic surgery through advanced technology. Founded in 2012 in Hasbrouck Heights, New Jersey, by Michael Phipps, the company has raised USD 9.00 mn in its SERIES A funding round co-led by Apis Holdings and Numeta Capital in June 2021. Enhatch has completed 6 deals to date and operates primarily in North America and Europe.Enhatch specializes in AI-driven orthopedic preoperative planning solutions, with an emphasis on 3D printing personalized implants and surgical guides. Their platform allows surgical teams, engineers, and representatives to collaborate remotely on patient-specific cases efficiently. Integrating with 3D Systems, Enhatch enables users to plan and print customized solutions seamlessly, catering to hospitals and surgical centers that seek innovative approaches to orthopedic surgeries.Enhatch generates revenue through a subscription model, granting access to its web-based portal designed for managing patient-specific solutions. Clients subscribe for unlimited users and cases, with no additional costs for individual products. Collaborative efforts with 3D Systems enhance their service offerings, providing end-to-end plan-and-print capabilities. Their pricing structure is adaptable, benefiting both large hospitals and smaller surgical practices.Following their most recent funding round in June 2021, Enhatch plans to utilize the USD 9.00 mn raised to expand its workforce and integrate Intelligent Surgery across the medical device sector. The company is also strategizing to launch new products targeting enhanced surgical outcomes and aims to penetrate additional markets by expanding its presence in Europe and North America. Specific timelines for these initiatives have yet to be disclosed.

## Funding rounds

- Series A, Jun 21, 2021, $9M — Numeta Capital, Apis Holdings
- Seed, Mar 7, 2016 — Floodgate, Visionnaire Ventures
- Seed, Aug 7, 2014 — Altair Capital

## Investors

- Altair Capital — Seed
- Floodgate (https://capitalatlas.ai/funds/floodgate) — Seed
- Visionnaire Ventures (https://capitalatlas.ai/funds/visionnaire-ventures) — Seed
- Numeta Capital (https://capitalatlas.ai/funds/numeta-capital) — Series A
- Apis Holdings (https://capitalatlas.ai/funds/apis-holdings) — Series A